Day RO - Search Results

1

Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?

Harvey KJ, Day RO, Campbell WG, Lipworth W. Harvey KJ, et al. Among authors: day ro. Med J Aust. 2011 Jun 6;194(11):567-8. doi: 10.5694/j.1326-5377.2011.tb03105.x. Med J Aust. 2011. PMID: 21644867

2

Why is disulfiram not on the PBS?

Lipworth WL, Wodak AD, Haber PS, Day RO. Lipworth WL, et al. Among authors: day ro. Med J Aust. 2011 Oct 3;195(7):371-2. doi: 10.5694/mja11.10708. Med J Aust. 2011. PMID: 21978330 No abstract available.

3

Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency.

Lipworth WL, Ho K, Kerridge IH, Day RO. Lipworth WL, et al. Among authors: day ro. Med J Aust. 2012 Aug 20;197(4):204-5. doi: 10.5694/mja11.11572. Med J Aust. 2012. PMID: 22900859 No abstract available.

4

The economic evaluation of personalised oncology medicines: ethical challenges.

Lewis JR, Lipworth WL, Kerridge IH, Day RO. Lewis JR, et al. Among authors: day ro. Med J Aust. 2013 Oct 7;199(7):471-3. doi: 10.5694/mja13.10046. Med J Aust. 2013. PMID: 24099207

5

Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment.

Inam S, Lipworth WL, Kerridge IH, Day RO. Inam S, et al. Among authors: day ro. Med J Aust. 2011 Oct 17;195(8):446-7. doi: 10.5694/mja11.10068. Med J Aust. 2011. PMID: 22004386 No abstract available.

6

Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda.

Lipworth WL, Kerridge I, Day RO. Lipworth WL, et al. Among authors: day ro. Med J Aust. 2012 Apr 2;196(6):374-5. doi: 10.5694/mja12.10152. Med J Aust. 2012. PMID: 22471530 Free article. No abstract available.

7

Ethics & evidence in medical debates: the case of recombinant activated factor VII.

Ghinea N, Lipworth W, Kerridge I, Little M, Day RO. Ghinea N, et al. Among authors: day ro. Hastings Cent Rep. 2014 Mar-Apr;44(2):38-45. doi: 10.1002/hast.287. Epub 2014 Feb 14. Hastings Cent Rep. 2014. PMID: 24532448

8

Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk.

Milder TY, Williams KM, Ritchie JE, Lipworth WL, Day RO. Milder TY, et al. Among authors: day ro. Age Ageing. 2011 Mar;40(2):254-9. doi: 10.1093/ageing/afq160. Epub 2010 Dec 26. Age Ageing. 2011. PMID: 21187281

9

Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization.

Lipworth WL, Kerridge IH, Day RO. Lipworth WL, et al. Among authors: day ro. Ther Innov Regul Sci. 2013 Jan;47(1):46-49. doi: 10.1177/2168479012469949. Ther Innov Regul Sci. 2013. PMID: 30227492

10

No evidence or no alternative? Taking responsibility for off-label prescribing.

Ghinea N, Lipworth W, Kerridge I, Day R. Ghinea N, et al. Intern Med J. 2012 Mar;42(3):247-51. doi: 10.1111/j.1445-5994.2012.02713.x. Intern Med J. 2012. PMID: 22432984 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters